ArticleCancers2022

Safety and Immunogenicity of Combined DNA-Polyethylenimine and Oral Bacterial Idiotypic Vaccine for Patients with B-Cell Non-Hodgkin Lymphoma: A Pilot Study.

Alexander Meleshko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.